US Bancorp
CTMX icon

US Bancorp’s CytomX Therapeutics CTMX Stock Holding History

US Bancorp’s Portfolio CTMX Stock Details CTMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-7,392
Closed -$4.7K – 4190
2025
Q1 		$4.7K Sell
7,392
-23,400
-76% -$18.1K ﹤0.01% 3678
2024
Q4 		$31.7K Sell
30,792
-3,000
-9% -$3.23K ﹤0.01% 2955
2024
Q3 		$39.9K Buy
+33,792
New +$42.9K ﹤0.01% 2848
2022
Q1 		– Sell
-50
Closed – – 4079
2021
Q4 		$0 Buy
+50
New +$293 ﹤0.01% 4113
2020
Q3 		– Sell
-309
Closed -$3K – 3726
2020
Q2 		$3K Buy
309
+105
+51% +$975 ﹤0.01% 3421
2020
Q1 		$2K Hold
204
– – ﹤0.01% 3445
2019
Q4 		$2K Buy
+204
New +$1.38K ﹤0.01% 3462

Other funds holding CTMX

VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return